Several studies have shown that IgG anti-oxLDL/β2GPI antibody levels are higher in SLE patients than in healthy controls, and even higher in SLE patients with APS as compared to the ones without APS. This evidence concerns the gene APOH and autoimmune polyendocrinopathy.